We are live on ! Find out more
Northern Trust

Northern Trust Portfolio holdings

AUM $757B
1-Year Est. Return 28.64%
 

Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.

This Fund
S&P 500
This Quarter Est. Return
+11.25%
1 Year Est. Return
+28.64%
3 Year Est. Return
+94.48%
5 Year Est. Return
+125.76%
10 Year Est. Return
+523.41%
AUM
$610B
AUM Growth
+$45.5B
Cap. Flow
-$6.38B
Cap. Flow %
-1.05%
Top 10 Hldgs %
22.82%
Holding
4,871
New
218
Increased
1,492
Reduced
2,680
Closed
100

Sector Composition

Rank Sector Weight
1 Technology 24.64%
2 Healthcare 12.43%
3 Financials 11.77%
4 Consumer Discretionary 11.33%
5 Communication Services 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLPN icon
4426
Dolphin Entertainment
DLPN
$14.7M
$100K ﹤0.01%
5,885
AUGX
4427
DELISTED
Augmedix, Inc. Common Stock
AUGX
$100K ﹤0.01%
+31,655
New +$115K
DCTH icon
4428
Delcath Systems
DCTH
$580M
$99K ﹤0.01%
12,743
ROI
4429
DELISTED
RiskOn International, Inc. Common Stock
ROI
$99K ﹤0.01%
1,487
+764
+106% +$81.1K
BIOC
4430
DELISTED
Biocept, Inc.
BIOC
$99K ﹤0.01%
911
CLVR
4431
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$98K ﹤0.01%
1,059
GSEV
4432
DELISTED
Gores Holdings VII, Inc. Class A Common Stock
GSEV
$98K ﹤0.01%
10,000
MACK
4433
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$98K ﹤0.01%
25,151
REFR icon
4434
Research Frontiers
REFR
$16.4M
$97K ﹤0.01%
56,231
-117
-0.2% -$251
CPIX icon
4435
Cumberland Pharmaceuticals
CPIX
$119M
$96K ﹤0.01%
20,617
+396
+2% +$1.35K
GGAL icon
4436
Galicia Financial Group
GGAL
$7.02B
$96K ﹤0.01%
10,138
-7,756
-43% -$79.8K
UBX
4437
DELISTED
Unity Biotechnology
UBX
$96K ﹤0.01%
6,620
CRKN
4438
DELISTED
Crown Electrokinetics Corp. Common Stock
CRKN
0
CEMI
4439
DELISTED
Chembio diagnostics, Inc.
CEMI
$95K ﹤0.01%
83,240
-602
-0.7% -$1.23K
MBRX icon
4440
Moleculin Biotech
MBRX
$3.28M
$94K ﹤0.01%
135
PPIH
4441
Perma-Pipe International
PPIH
$216M
$94K ﹤0.01%
10,828
-2,154
-17% -$18.1K
GMBL
4442
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
$94K ﹤0.01%
1
ZSAN
4443
DELISTED
Zosano Pharma Corporation
ZSAN
$94K ﹤0.01%
5,700
VISL
4444
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$94K ﹤0.01%
3,998
COCP icon
4445
Cocrystal Pharma
COCP
$15.3M
$93K ﹤0.01%
11,956
GYRE icon
4446
Gyre Therapeutics
GYRE
$716M
$93K ﹤0.01%
13,621
-162
-1% -$2.77K
NVNO
4447
enVVeno Medical
NVNO
$7.31M
$92K ﹤0.01%
397
ASPU
4448
DELISTED
ASPEN GROUP, INC.
ASPU
$92K ﹤0.01%
39,017
KINS icon
4449
Kingstone Companies
KINS
$282M
$91K ﹤0.01%
18,119
VOC icon
4450
VOC Energy
VOC
$53.7M
$91K ﹤0.01%
19,354
+5,894
+44% +$28.4K

Similar funds

Northern Trust's Q4 2021 Portfolio in Review

As of Q4 2021, Northern Trust held 4,871 positions worth $610B, up 8% from $565B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Northern Trust's Q4 2021 filing shows 218 new, 1,492 increased, 2,680 reduced and 100 closed positions. Its largest new stake was Rivian: 874,044 shares worth $90.6M. The largest sale was Apple, an estimated $703M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Northern Trust's largest Q4 2021 buy was Rivian: 874,044 shares worth $90.6M.
  • Northern Trust added most to iShares Russell 1000 ETF in Q4 2021, an estimated $272M increase.
  • Northern Trust's biggest Q4 2021 reduction was Apple, cutting an estimated $703M.
  • Northern Trust fully exited Kansas City Southern in Q4 2021, selling an estimated $278M.
  • Northern Trust's ten largest holdings make up 23% of its $610B portfolio in Q4 2021.
  • Northern Trust opened 218 new positions and closed 100 in Q4 2021.
  • Northern Trust's portfolio value rose 8% quarter-over-quarter to $610B.

Based on Northern Trust's 13F filing for Q4 2021, filed 8 Feb 2022.